Salvianolic Acid B Prevents Arsenic Trioxide-Induced Cardiotoxicity In Vivo and Enhances Its Anticancer Activity In Vitro

Figure 5

Effects of Sal B on the apoptosis of cancer cells induced by ATO. Annexin V-FITC/PI flow-cytometric data from HepG2 (a) and HeLa (b) cells treated with ATO, Sal B, or both (4 μM ATO, 10 μM Sal B) for 48 h. The data are expressed as means ± SD from three independent experiments. **𝑃<0.01 versus control; ^#𝑃<0.05 versus ATO-treated cells; ^##𝑃<0.01 versus ATO-treated cells.

(a)

(b)